Did you know? You can suggest edits to improve this peptide information.
Overview
What is CJC-1295 (without DAC)?
CJC-1295 without DAC, also known as Modified GRF 1-29 or Mod GRF 1-29, is a synthetic analog of growth hormone releasing hormone (GHRH). This short-acting variant stimulates pulsatile growth hormone release, mimicking the body's natural GH secretion patterns. Unlike its DAC-modified counterpart, this version has a brief half-life of approximately 30 minutes, allowing for more precise control over growth hormone pulses and reduced risk of receptor desensitization.
Key Benefits
Preserves natural GH pulsatility, minimal side effects, no receptor desensitization, precise control over GH release
Mechanism of Action
Binds to GHRH receptors on somatotroph cells, stimulating cAMP production and triggering growth hormone release in physiological pulses
Molecular Information
Weight
3,367.97 Da
Length
30 amino acids
Type
GHRH analog (Mod GRF 1-29)
Amino Acid Sequence:
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys
* Modified GHRH(1-29) with enhanced stability, requires frequent dosing
Pharmacokinetics
Research Indications
Natural GH Pulse Restoration
Stimulates physiological growth hormone pulses that decline with age
IGF-1 Elevation
Increases insulin-like growth factor 1 levels through enhanced GH secretion
Pituitary Function Support
Maintains healthy pituitary-somatotroph axis without suppression
Research Protocols
Disclaimer
These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing
Administer 30+ minutes away from food for optimal absorption. Morning dose upon waking, evening dose before bed for best results.
Peptide Interactions
How to Reconstitute
Important
Always use bacteriostatic water (BAC). Sterile technique is essential.
Allow vial to reach room temperature (15-20 minutes)
Clean vial top with alcohol swab and allow to dry
Calculate required bacteriostatic water volume using the calculator below
Draw calculated volume of bacteriostatic water into syringe
Inject water slowly down the inside wall of the vial (never directly onto powder)
Gently swirl until powder completely dissolves (never shake)
Solution should be clear - discard if cloudy or contains particles
Store reconstituted solution in refrigerator at 2-8°C
Quality Indicators
Legitimate source with COA
Purchase from vendors providing certificates of analysis showing >98% purity
Proper cold chain shipping
Peptide should arrive with ice packs or refrigerated shipping in hot weather
Vacuum-sealed vials
Legitimate peptides create vacuum when reconstituted - water should be pulled in
Check expiration dates
Lyophilized peptide typically stable for 2 years if stored properly
Pre-mixed solutions
Avoid pre-reconstituted products - peptide degrades rapidly in solution
Discolored powder
White to off-white powder only - yellow or brown indicates degradation
What to Expect
- Day 1-7: Improved sleep quality, vivid dreams common due to enhanced REM sleep
- Week 2-4: Increased recovery from workouts, reduced DOMS, better pumps
- Week 4-8: Noticeable improvements in skin quality, minor body composition changes
- Week 8-12: More significant lean mass gains, fat loss, improved joint comfort
- Week 12+: Continued gradual improvements in body composition and well-being
Side Effects & Safety
- Generally well-tolerated with minimal side effects at recommended doses
- May cause temporary facial flushing or warmth for 5-10 minutes post-injection
- Monitor blood glucose if diabetic - GH can affect insulin sensitivity
- Not recommended for those with active cancer due to growth-promoting effects
- Avoid if you have diabetic retinopathy or severe kidney disease
References
Long-term Safety Profile of Modified GRF Analogs (2015)
No significant adverse effects on pituitary morphology or function with chronic use, supporting the safety of long-term pulsatile GHRH analog administration.
Comparative Analysis: CJC-1295 vs Native GHRH (2010)
Found CJC-1295 without DAC had 4x greater receptor affinity than native GHRH and enhanced resistance to enzymatic degradation, explaining its superior efficacy.
Growth Hormone Pulsatility with Mod GRF 1-29 (2008)
Showed preservation of natural GH pulsatility patterns when administered 3 times daily, with no evidence of pituitary desensitization over the study period.
Quick Start Guide
Community Poll
Question 1 of 10
What is your experience with this compound?
Poll Results
Loading results...
Community Insights
Self-reported by PepPedia users. Not clinical evidence. Health changes reflect all users, including those taking multiple compounds.
Was this helpful?
Your feedback helps us improve PepPedia